
Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

